Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves
Authors
Keywords
Vaccination and immunization, Vaccines, Age groups, Intensive care units, Viral vaccines, Immunity, Germany, COVID 19
Journal
PLoS Computational Biology
Volume 17, Issue 9, Pages e1009288
Publisher
Public Library of Science (PLoS)
Online
2021-09-03
DOI
10.1371/journal.pcbi.1009288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological characteristics govern the transition of COVID-19 to endemicity
- (2021) Jennie S. Lavine et al. SCIENCE
- Inferring high-resolution human mixing patterns for disease modeling
- (2021) Dina Mistry et al. Nature Communications
- The challenges of containing SARS-CoV-2 via test-trace-and-isolate
- (2021) Sebastian Contreras et al. Nature Communications
- Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study
- (2021) Brody H. Foy et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A control theory approach to optimal pandemic mitigation
- (2021) Prakhar Godara et al. PLoS One
- Immunity to SARS-CoV-2 variants of concern
- (2021) Daniel M. Altmann et al. SCIENCE
- Covid-19: Where are we on vaccines and variants?
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Isolation and Contact Tracing Can Tip the Scale to Containment of COVID-19 in Populations With Social Distancing
- (2021) Mirjam E. Kretzschmar et al. Frontiers in Physics
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
- (2021) Debra Van Egeren et al. PLoS One
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- (2021) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Estimating the burden of SARS-CoV-2 in France
- (2020) Henrik Salje et al. SCIENCE
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
- (2020) Ruiyun Li et al. SCIENCE
- SARS-CoV-2 (COVID-19) by the numbers
- (2020) Yinon M Bar-On et al. eLife
- Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
- (2020) Christian Karagiannidis et al. Lancet Respiratory Medicine
- Apples and oranges: international comparisons of COVID-19 observational studies in ICUs
- (2020) Jonathan E Millar et al. Lancet Respiratory Medicine
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now